Highest-materiality recent filing
Net increase in net assets resulting from operations of $10.7M ($0.26/sh) vs $13.2M ($0.33/sh) in Q2 2025.
TPVG Q1 NII $0.23/share, down from $0.27 YoY; declares $0.23 dividend; authorizes $12.5M buyback
Net investment income $9.1M ($0.23/share) vs $10.7M ($0.27) in Q1 2025; total investment income $22.8M vs $22.5M.
TPVG reports FY2025 NII of $1.05/share; NAV rises to $8.73; declares $0.23 Q1 distribution
NII of $42.3M ($1.05/sh) for FY2025 vs $54.5M ($1.40/sh) in FY2024; Q4 NII $9.9M ($0.25/sh).
TPVG amends credit facility, extends revolving period to 2027, maturity to 2029 with improved terms
Extended revolving period to Nov 30, 2027, and maturity to May 30, 2029.
TPVG Q3: NII $0.26/sh; debt commitments at 3-yr high; dividend $0.25/sh; adviser extends fee waiver
NII $10.3M ($0.26/sh); net increase in net assets $15.2M ($0.38/sh) for Q3 2025.
TPVG Q2 2025 NII $0.28/sh; NAV $8.65; declares $0.23 dividend; Sponsor to buy up to $14M stock
Closed $160.1M debt commitments, highest in 3 years; funded $78.5M, up 188% QoQ.
TPVG Q1 net increase from ops $0.32/share; NII $0.27/share; declares $0.30 dividend
Net investment income of $10.7M ($0.27 per share) vs $15.5M ($0.41) in Q1 2024; total investment income $22.5M vs $29.3M.
TriplePoint Venture Growth Q4 NII $0.32/share; FY 2024 NII $1.40/share; declares Q1 dividend $0.30
Q4 2024 NII $12.6M ($0.32/share) vs $17.3M ($0.47/share) in Q4 2023; total investment income $25.8M.
TPVG Q3 NII $0.35/sh, NAV $9.10 (+$0.27); declares Q4 $0.30 distribution
Net investment income $13.8M ($0.35/sh) vs $19.1M ($0.54/sh) in Q3 2023.
On August 7, 2024, the U.S. District Court for N.D. Cal. granted defendants' motion to dismiss the putative class action (Case 3:23-cv-02980).
Revolving period extended to Nov 30, 2025; maturity extended to May 30, 2027.
TPVG Q2 2024 NII $0.33/shr vs $0.53 last year; NAV $8.83; dividend $0.30
Net investment income $12.6M ($0.33/shr) vs $18.8M ($0.53) a year ago; total investment income $27.1M.
TriplePoint Venture Growth BDC enters $75M ATM equity offering with UBS
New sales agreement with UBS Securities LLC for up to $75M of common stock (TPVG).
TPVG Q1 NII $0.41/share, total investment income $29.3M; NAV $9.02
Net investment income $15.5M ($0.41/share) vs $18.6M ($0.53/share) in Q1 2023.
TPVG reports FY2023 NII $2.07/share, NAV down to $9.21, Q4 realized losses $52M
Net investment income FY2023: $73.8M or $2.07 per share; Q4 NII $17.3M or $0.47 per share.
TriplePoint Venture Growth Q3 NII $0.54/share, declares $0.40 distribution
NII $19.1M ($0.54/share) up from $16.9M ($0.51) YoY; total investment income $35.7M.
TPVG borrower ForgeRock acquired; $30M loan prepaid, $3.6M fees, $2.3M income acceleration
ForgeRock acquired by Thoma Bravo in $2.3B all-cash deal; TPVG's $30.0M loan fully prepaid.
TriplePoint Venture Growth Q2 NII $0.53/sh; NAV down to $10.70; declares $0.40 dividend
Q2 NII $18.8M ($0.53/sh) vs $12.7M ($0.41) in Q2 2022; total investment income $35.2M.
TriplePoint Venture Growth Q1 NII $0.53/share; three portfolio companies file for bankruptcy
Net investment income $18.6M ($0.53/share); total investment income $33.6M; NAV $414.0M ($11.69/share).
TPVG reports record Q4 NII of $0.58/share; raises dividend 8% to $0.40
Record Q4 total investment income $34.9M; net investment income $20.5M ($0.58/share).
TriplePoint borrower Medly Health files Ch 11; TPVG expects full write-down of investments
Medly Health Inc. filed for Chapter 11 on Dec 9, 2022 due to irregularities and liquidity issues.
Record portfolio fair value of $962M and net investment income of $16.9M ($0.51/sh) for Q3 2022.
TriplePoint Venture Growth BDC raises ~$49.8M in public offering of 3.5M shares
Entered underwriting agreement Aug 4, 2022 for 3,500,000 common shares (plus 562,500 option).
TPVG Q2 NII $0.41, record portfolio $877M; NAV slips to $13.01, Q3 dividend $0.36
Net investment income $12.7M ($0.41/share); 14.5% weighted avg portfolio yield on debt.
TriplePoint Venture Q1 NII $0.44/share, declares $0.36 dividend
Net investment income of $13.5M ($0.44/share), up from $0.42/share prior quarter; 12.6% ROE.
Q4 NII $0.42/sh, record portfolio $865M; declares $0.36 Q1 dividend
Net investment income $12.9M ($0.42/sh) in Q4, up from $9.9M ($0.32/sh) prior quarter; FY2021 NII $41.1M ($1.33/sh).
TriplePoint Venture Growth posts record portfolio fair value $767M; NAV per share up $0.89 to $13.92
Record portfolio fair value of $767M; NAV per share increased $0.89 to $13.92 (7% QoQ).
TPVG Q2 2021 NII $0.30/share, NAV $13.03; declares $0.36 Q3 dividend
Net investment income of $9.4M ($0.30/share) vs $11.5M ($0.38) in Q2 2020.
On August 2, 2024, the Board of Directors of TriplePoint Venture Growth BDC Corp. (the “Company”) appointed Matthew A. Galiani to serve as interim Chief Financial Officer of the Company, effective as of the close of business on August 9, 2024.
On June 14, 2024, TriplePoint Venture Growth BDC Corp. (the “Company”) announced Christopher M. Mathieu’s plans to retire as Chief Financial Officer of the Company, effective as of the close of business on August 9, 2024.
appointed (i) Katherine J. Park as a Class III director and (ii) Kimberley Vogel as a Class II director to fill the vacancies created by such increase, each effective immediately.
appointed (i) Katherine J. Park as a Class III director and (ii) Kimberley Vogel as a Class II director to fill the vacancies created by such increase, each effective immediately.
Max materiality 0.85 · Median 0.65 · Most common event earnings